205 related articles for article (PubMed ID: 17904544)
1. Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
Liu J; Li X; Cheng YN; Cui SX; Chen MH; Xu WF; Tian ZG; Makuuchi M; Tang W; Qu XJ
Eur J Pharmacol; 2007 Nov; 574(1):1-7. PubMed ID: 17904544
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human gastric carcinoma cell growth by atofluding derivative N3-o-toluyl-fluorouracil.
Liu J; Xu WF; Cui SX; Zhou Y; Yuan YX; Chen MH; Wang RH; Gai RY; Makuuchi M; Tang W; Qu XJ
World J Gastroenterol; 2006 Nov; 12(42):6766-70. PubMed ID: 17106923
[TBL] [Abstract][Full Text] [Related]
3. N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.
Zhang X; Zhong JL; Liu W; Gao Z; Xue X; Yue P; Wang L; Zhao C; Xu W; Qu X
Cancer Chemother Pharmacol; 2010 May; 66(1):11-9. PubMed ID: 19756602
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
Wu DD; Xiao YF; Geng Y; Hou J
Cancer Genet Cytogenet; 2010 Apr; 198(2):90-6. PubMed ID: 20362223
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest.
Li J; Tu HJ; Li J; Dai G; Dai YC; Wu Q; Shi QZ; Cao Q; Li ZJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):769-74. PubMed ID: 17700262
[TBL] [Abstract][Full Text] [Related]
6. The in vitro anti-tumor efficacy and the pharmacokinetics of N3-o-toluyl-fluorouracil loaded nanosuspension (TFu-LNS).
Li M; Zhang J; Feng L; Zhang L; Zhang N
J Biomed Nanotechnol; 2013 May; 9(5):801-10. PubMed ID: 23802409
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
Sun W; Zhang N; Li A; Zou W; Xu W
Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
[TBL] [Abstract][Full Text] [Related]
8. 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice.
Inada T; Ichikawa A; Kubota T; Ogata Y; Moossa AR; Hoffman RM
Anticancer Res; 1997; 17(3C):1965-71. PubMed ID: 9216653
[TBL] [Abstract][Full Text] [Related]
9. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
10. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
Zhang SH; Chen J; Jiang M; Zhen YS
Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
[TBL] [Abstract][Full Text] [Related]
11. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
12. Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil.
Sugamura K; Makino M; Shirai H; Kimura O; Maeta M; Itoh H; Kaibara N
Cancer; 1997 Jan; 79(1):12-7. PubMed ID: 8988721
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil on gastric cancer cell lines.
Taomoto J; Yoshida K; Wada Y; Tanabe K; Konishi K; Tahara H; Fukushima M
Oncology; 2006; 70(6):458-64. PubMed ID: 17237621
[TBL] [Abstract][Full Text] [Related]
14. Potent antitumor effects of a novel actinomycin D analog Leu5AMD.
Wang KR; Zhang BZ; Zhang W; Yan JX; Li X; Wang R
Cancer Lett; 2008 Sep; 268(1):38-45. PubMed ID: 18448241
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
17. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine.
Sun JY; Zhu MZ; Wang SW; Miao S; Xie YH; Wang JB
Phytomedicine; 2007 May; 14(5):353-9. PubMed ID: 17097281
[TBL] [Abstract][Full Text] [Related]
19. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
